Skip to main content
. 2015 Dec 19;7(3):2754–2764. doi: 10.18632/oncotarget.6666

Figure 3. ROC curves for the interest biomarkers and top three combinations.

Figure 3

C1: POU4F2 + EOMES, C2: POU4F2 + PCDH17, C3: POU4F2 + PCDH17 + GDF15.